Assignee
SCHABAR RES ASSOCIATES LLC
US·6 granted patents·4 pending applications·11 citations·filing 2014–2025
Top patents by PatentIndex Score
10 records- 0195US11331307B2Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburnSCHABAR RES ASSOCIATES LLC·Filed 2021·Granted May 17, 2022·4 cites·26 claims
- 0293US12053457B2Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburnSCHABAR RES ASSOCIATES LLC·Filed 2022·Granted Aug 6, 2024·2 cites·53 claims
- 0390US9044465B2Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compoundSCHABAR RES ASSOCIATES LLC·Filed 2014·Granted Jun 2, 2015·5 cites·38 claims
- 0477US2026097023A1Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomachSCHABAR RES ASSOCIATES LLC·Filed 2025·Application pending·0 cites
- 0572US12514846B2Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomachSCHABAR RES ASSOCIATES LLC·Filed 2022·Granted Jan 6, 2026·0 cites·36 claims
- 0672US12048690B2Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburnSCHABAR RES ASSOCIATES LLC·Filed 2022·Granted Jul 30, 2024·0 cites·13 claims
- 0771US2018303801A1Unit oral solid dose compositions composed of ibuprofen and nizatidineSCHABAR RES ASSOCIATES LLC·Filed 2018·Application pending·0 cites
- 0869US11324727B2Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburnSCHABAR RES ASSOCIATES LLC·Filed 2021·Granted May 10, 2022·0 cites·20 claims
- 0962US2015272932A1Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compoundSCHABAR RES ASSOCIATES LLC·Filed 2015·Application pending·0 cites
- 1055US2015272933A1Unit oral solid dose compositions composed of a pharmaceutically acceptable salt of naproxen and nizatidine or the pharmaceutically acceptable salt thereofSCHABAR RES ASSOCIATES LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SCHABAR RES ASSOCIATES LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →